AI in Healthcare
The latest on artificial intelligence transforming medicine
News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.
Why Protein Flexibility Is Emerging as the Next Frontier in AI Drug Design
A new AI platform that models protein flexibility highlights a key limitation in current drug discovery workflows: many models still treat proteins too rigidly. Better representation of structural movement could improve the fidelity of computational design and reduce late-stage failure.
NVIDIA’s New Drug Discovery Model Signals the Compute Stack Is Becoming a Therapeutics Battleground
NVIDIA’s release of a new AI model for drug discovery highlights how foundational model providers are moving deeper into life sciences. The competitive question is no longer whether tech infrastructure companies will influence biopharma R&D, but how much value they can capture relative to drug developers and platform biotechs.
Xaira’s Virtual Cell Push Suggests AI Biotech Is Moving From Molecules to Whole-System Models
Xaira says its first virtual cell model is the largest to date, pointing toward a more ambitious vision for AI in biology. Rather than focusing only on molecule generation, virtual cell approaches aim to model cellular behavior more comprehensively, which could eventually reshape how targets, mechanisms, and interventions are evaluated.
A New Review Makes the Case for AI in Antiviral Discovery, but Biology Remains the Constraint
A ScienceDirect review examines whether artificial intelligence can transform antiviral drug discovery, framing both the promise and the practical limits of computational approaches in infectious disease. The article is timely as governments and industry continue searching for faster pandemic-response capabilities without overestimating what models can deliver absent strong virology and translational data.
New AI Model Highlights a Familiar Truth in Drug Discovery: Better Models Matter Only if Experiments Keep Up
A report on an AI model that accelerates therapeutic drug discovery points to ongoing technical progress in model-guided candidate generation and prioritization. But its broader significance is as a reminder that the field’s central bottleneck is increasingly the translation of computational gains into experimental throughput and validated biology.
How this works
Discover
An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.
Structure
The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.
Publish
Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.